Titan Pharmaceuticals, Inc. (TTNP)
TTNP moved a median of +0.47% 30 minutes after news, and +0.57% by the close. How TTNP actually reacts to news — the realized, point-in-time move the market made, measured across 94 labeled events over the last three years with zero look-ahead.
TTNP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 51 |
| 30-min | +0.47% | 61% | 62 |
| 60-min | +0.22% | 59% | 71 |
| to close | +0.57% | 56% | 78 |
| Middle 50% of TTNP reactions | -0.88% to +4.24% |
|---|---|
| Median reaction (30-min) | +0.47% |
| Measured reactions | 94 |
Half of all Titan Pharmaceuticals, Inc. news events land between -0.88% and +4.24% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when TTNP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TTNP's baseline. Nothing else.
Recent TTNP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G TITAN PHARMACEUTICALS | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form POS AM TITAN PHARMACEUTICALS | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS TITAN PHARMACEUTICALS | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 8-K TITAN PHARMACEUTICALS For: Oct 01 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K TITAN PHARMACEUTICALS For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | -0.98% | -7.25% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | SEC EDGAR | — | +0.00% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -1.40% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | SEC EDGAR | — | -1.40% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.51% | |
| Form DEFM14A TITAN PHARMACEUTICALS | SEC filing · Form DEFM14A | SEC EDGAR | +0.00% | +1.51% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | — | -1.18% | |
| Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock | Press release | GlobeNewswire | — | -1.18% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.41% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | +2.88% | +6.65% | |
| Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. | Press release | GlobeNewswire | +3.35% | +6.47% | |
| Form 8-K TITAN PHARMACEUTICALS For: May 30 | SEC filing · Form 8-K | SEC EDGAR | +3.35% | +6.47% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +8.14% | +4.07% | |
| Form DEF 14A TITAN PHARMACEUTICALS For: Jun 16 | SEC filing · Form DEF | SEC EDGAR | — | +3.23% | |
| Form DEFA14A TITAN PHARMACEUTICALS | SEC filing · Form DEFA14A | SEC EDGAR | — | +3.23% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.37% | |
| Form PRE 14A TITAN PHARMACEUTICALS For: Apr 22 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +1.37% | |
| Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock | Press release | GlobeNewswire | -2.03% | +1.35% | |
| Form 8-K TITAN PHARMACEUTICALS For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | — | +1.27% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +15.75% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 03 | SEC filing · Form 8-K | SEC EDGAR | — | -0.89% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.71% | +2.17% | |
| Form 8-K TITAN PHARMACEUTICALS For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | — | -7.38% | |
| Form 8-K TITAN PHARMACEUTICALS For: Nov 22 | SEC filing · Form 8-K | SEC EDGAR | +3.59% | -3.08% | |
| Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq | Press release | GlobeNewswire | +3.59% | -3.08% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | -2.13% | |
| Form 8-K TITAN PHARMACEUTICALS For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | — | +4.06% | |
| Form 8-K TITAN PHARMACEUTICALS For: Oct 24 | SEC filing · Form 8-K | SEC EDGAR | -1.47% | -8.08% | |
| Form 8-K TITAN PHARMACEUTICALS For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | +9.89% | +12.36% | |
| Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. | Press release | GlobeNewswire | +9.89% | +12.36% | |
| TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders | Press release | Business Wire | +9.89% | +12.36% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -2.71% | |
| Form NT 10-Q TITAN PHARMACEUTICALS For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | -2.71% | |
| Form 10-Q TITAN PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.55% | +0.79% | |
| Form RW TITAN PHARMACEUTICALS | SEC filing · Form RW | SEC EDGAR | +0.24% | -5.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.50% | |
| Form 10-K TITAN PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +4.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | — | +4.21% | |
| Form 8-K TITAN PHARMACEUTICALS For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | — | -4.11% | |
| Form 8-K TITAN PHARMACEUTICALS For: Feb 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +8.36% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 24 | SEC filing · Form 8-K | SEC EDGAR | — | +0.57% | |
| Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria | Press release | GlobeNewswire | — | +0.57% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 11 | SEC filing · Form 8-K | SEC EDGAR | — | -0.16% | |
| Form 8-K TITAN PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -15.34% | |
| Form 8-K TITAN PHARMACEUTICALS For: Dec 27 | SEC filing · Form 8-K | SEC EDGAR | +4.58% | +15.32% | |
| Titan Pharmaceuticals Announces Reverse Stock Split and Ratio | Press release | GlobeNewswire | +4.58% | +15.32% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TTNP section they belong to.
Where else TTNP is measured.
TTNP earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ASTELLAS PHARMA UNSP/ADR (ALPMY) | 94 | +0.02% | 50% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
| COGNETIVITY NEUROSCIENCES (CGNSF) | 93 | 0.00% | 37% |
| ENZON PHARMS INC (ENZN) | 93 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Titan Pharmaceuticals, Inc.'s median reaction calculated?
Every labeled TTNP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 94 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 61% of TTNP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TTNP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.